LDLR and systemic lupus erythematosus: Knockout of ApoE or low density liproprotein receptor (LDLr) has also been applied to various SLE -specific mouse models to demonstrate the role of SLE pathways in worsening plaque formation in mice that are already prone to atherosclerosis (41, 43, 44, 50, 57).